Series B - Santa Ana Bio

Series B - Santa Ana Bio

Investment Firm

Overview

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Announced Date

Jun 13, 2024

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Google Ventures

Google Ventures

Google Ventures is a convertible_note and crowdfunding and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorRTW Investments
Participant InvestorAccess Biotechnology
Participant InvestorAndreessen Horowitz
Participant InvestorGoogle Ventures

Round Details and Background

Santa Ana Bio raised $125000000 on 2024-06-13 in Series B

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 28, 2023
Series A - Santa Ana Bio
3-43.0M
Jun 13, 2024
Series B - Santa Ana Bio
4-125.0M
Jun 01, 2021
Venture Round - Santa Ana Bio
-8.0M

Recent Activity

There is no recent news or activity for this profile.